Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Webcasts and audio

Audio Link PDF
Preliminary Results for the year ended 31 December 2025
Jefferies Global Healthcare Conference 2025 - 15 December 2025
Webinar: Optimising Viral Vector Manufacturing with CDMO Expertise and Innovation - 18 November 2025
Stifel US Healthcare Conference 2025 - 17 November 2025
Webinar: Driving Down the Cost- Optimising CGT with the Right CDMO Partner - 13 November 2025
Interim results for 6 months ended 30 June 2025 - 2 October 2025
Presentation: Accelerate Time to Clinic - A Platform and Analytics Approach
Preliminary results for the year ended 31 December 2024 - 17 April 2025
Jefferies London Healthcare conference presentation 2024 - 19 November 2024
Interim results for the six months ended 30 June 2024 - 23 September 2024
Preliminary Results of the year ended 31 December 2023 - 29 April 2024
42nd Annual J.P. Morgan Healthcare conference presentation - 10 January 2024
Interim results for the year ended 30 June 2023 - 20 September 2023
Preliminary results for the year ended 31 December 2022 - 25 April 2023
41st Annual J.P. Morgan Healthcare conference presentation - 11 January 2023
Interim results for the six months ended 30 June 2022 - 15 September 2022
Preliminary results for the year ended 31 December 2021 - 25 April 2022
Oxford Biomedica analyst briefing - 28 January 2022
Preliminary results for the year ended 31 December 2020 - 15 April 2021
Annual General Meeting, 23 June 2020 - 24 June 2020
Preliminary results for the year ended 31 December 2019 - 6 May 2020
Analyst Presentation: Interim results for the six months ended 30 June 2018 - 13 September 2018
Analyst conference call: Preliminary results for the year ended 31 December 2017 - 15 March 2018
Analyst conference call: Oxford BioMedica and Bioverativ Collaboration - 15 February 2018
Analyst Presentation: Interim results for the six months ended 30 June 2017
OXB-Investors-results and presentation-image grid 1-832x480px
OXB-Investors-results and presentation-image grid 2-832x480px
OXB-Investors-results and presentation-image grid 3-832x480px